SCHEMBL681806

SCHEMBL681806

C=C(C(C)C)[C@H](CCNC(C)C)c1ccc(Br)cc1

nearest known ligand 0.47

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.37
ALOX5 P09917 1/20 0.36
MAPT P10636 2/20 0.35
POLB P06746 1/20 0.35
CNR1 P21554 1/20 0.35
NPSR1 Q6W5P4 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
KDM4E B2RXH2 3/20 0.33
LMNA P02545 1/20 0.33
ALOX12 P18054 1/20 0.33
ALDH1A1 P00352 1/20 0.33
CYP2C19 P33261 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL681357 0.85 CYP1A2 (0.40) CYP1A2ALOX5MAPTPOLBCNR1
SCHEMBL17803819 0.85 KDM4E (0.42) CYP1A2POLBCNR1SMN1; SMN2KDM4E
SCHEMBL12194485 0.84 MAPT (0.43) CYP1A2MAPTPOLBKDM4ELMNA
SCHEMBL681348 0.84 MAPT (0.43) CYP1A2MAPTPOLBKDM4ELMNA
SCHEMBL12188508 0.83 CYP1A2 (0.45) CYP1A2ALOX5MAPTPOLBCNR1
SCHEMBL681418 0.82 ALDH1A1 (0.36) CYP1A2ALOX5MAPTCNR1NPSR1
SCHEMBL2738685 0.82 ALOX5 (0.46) CYP1A2ALOX5MAPTPOLBCNR1
SCHEMBL680223 0.80 ALOX5 (0.42) CYP1A2ALOX5SMN1; SMN2
SCHEMBL681240 0.79 ALOX5 (0.41) CYP1A2ALOX5MAPTCNR1SMN1; SMN2
SCHEMBL681301 0.77 ALOX5 (0.31) CYP1A2ALOX5POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9359340-B2 Hydroxylated and methoxylated pyrimidyl cyclopentanes as Akt protein kinase inhibitors ARRAY BIOPHARMA INC. (US) 2016-06-07 US disclosed
US-8063050-B2 Hydroxylated and methoxylated pyrimidyl cyclopentanes as AKT protein kinase inhibitors ARRAY BIOPHARMA INC. (US) 2011-11-22 US disclosed